Literature DB >> 28141790

Caffeine administration modulates TGF-β signaling but does not attenuate blunted alveolarization in a hyperoxia-based mouse model of bronchopulmonary dysplasia.

Philipp Rath1,2, Claudio Nardiello1,3, David E Surate Solaligue1,3, Ronald Agius4, Ivana Mižíková1,3, Sebastian Hühn2, Konstantin Mayer3, István Vadász3, Susanne Herold3, Frank Runkel2,5, Werner Seeger1,3, Rory E Morty1,3.   

Abstract

BACKGROUND: Caffeine is widely used to manage apnea of prematurity, and reduces the incidence of bronchopulmonary dysplasia (BPD). Deregulated transforming growth factor (TGF)-β signaling underlies arrested postnatal lung maturation in BPD. It is unclear whether caffeine impacts TGF-β signaling or postnatal lung development in affected lungs.
METHODS: The impact of caffeine on TGF-β signaling in primary mouse lung fibroblasts and alveolar epithelial type II cells was assessed in vitro. The effects of caffeine administration (25 mg/kg/d for the first 14 d of postnatal life) on aberrant lung development and TGF-β signaling in vivo was assessed in a hyperoxia (85% O2)-based model of BPD in C57BL/6 mice.
RESULTS: Caffeine downregulated expression of type I and type III TGF-β receptors, and Smad2; and potentiated TGF-β signaling in vitro. In vivo, caffeine administration normalized body mass under hyperoxic conditions, and normalized Smad2 phosphorylation detected in lung homogenates; however, caffeine administration neither improved nor worsened lung structure in hyperoxia-exposed mice, in which postnatal lung maturation was blunted.
CONCLUSION: Caffeine modulated TGF-β signaling in vitro and in vivo. Caffeine administration was well-tolerated by newborn mice, but did not influence the course of blunted postnatal lung maturation in a hyperoxia-based experimental mouse model of BPD.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28141790     DOI: 10.1038/pr.2017.21

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  10 in total

1.  Stereological analysis of individual lung lobes during normal and aberrant mouse lung alveolarisation.

Authors:  Tuong-Van Hoang; Claudio Nardiello; David E Surate Solaligue; José Alberto Rodríguez-Castillo; Philipp Rath; Konstantin Mayer; István Vadász; Susanne Herold; Kathrin Ahlbrecht; Werner Seeger; Rory E Morty
Journal:  J Anat       Date:  2018-01-09       Impact factor: 2.610

2.  Aurothioglucose does not improve alveolarization or elicit sustained Nrf2 activation in C57BL/6 models of bronchopulmonary dysplasia.

Authors:  Qian Li; Rui Li; Stephanie B Wall; Katelyn Dunigan; Changchun Ren; Tamas Jilling; Lynette K Rogers; Trent E Tipple
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-01-25       Impact factor: 5.464

3.  Loss of CD73-mediated extracellular adenosine production exacerbates inflammation and abnormal alveolar development in newborn mice exposed to prolonged hyperoxia.

Authors:  Huiling Li; Harry Karmouty-Quintana; Ning-Yuan Chen; Tingting Mills; Jose Molina; Michael R Blackburn; Jonathan Davies
Journal:  Pediatr Res       Date:  2017-08-23       Impact factor: 3.756

Review 4.  Mechanistic actions of oxygen and methylxanthines on respiratory neural control and for the treatment of neonatal apnea.

Authors:  Lisa Mitchell; Peter M MacFarlane
Journal:  Respir Physiol Neurobiol       Date:  2019-10-15       Impact factor: 1.931

Review 5.  The Future of Bronchopulmonary Dysplasia: Emerging Pathophysiological Concepts and Potential New Avenues of Treatment.

Authors:  Jennifer J P Collins; Dick Tibboel; Ismé M de Kleer; Irwin K M Reiss; Robbert J Rottier
Journal:  Front Med (Lausanne)       Date:  2017-05-22

6.  Antioxidative effects of caffeine in a hyperoxia-based rat model of bronchopulmonary dysplasia.

Authors:  Stefanie Endesfelder; Evelyn Strauß; Till Scheuer; Thomas Schmitz; Christoph Bührer
Journal:  Respir Res       Date:  2019-05-10

Review 7.  Perinatal Hyperoxia and Developmental Consequences on the Lung-Brain Axis.

Authors:  Stefanie Obst; Josephine Herz; Miguel A Alejandre Alcazar; Stefanie Endesfelder; Marius A Möbius; Mario Rüdiger; Ursula Felderhoff-Müser; Ivo Bendix
Journal:  Oxid Med Cell Longev       Date:  2022-02-24       Impact factor: 6.543

Review 8.  Molecular Mechanism of Caffeine in Preventing Bronchopulmonary Dysplasia in Premature Infants.

Authors:  Congliang Tian; Danni Li; Jianhua Fu
Journal:  Front Pediatr       Date:  2022-06-20       Impact factor: 3.569

Review 9.  Caffeine and Clinical Outcomes in Premature Neonates.

Authors:  Vasantha H S Kumar; Steven E Lipshultz
Journal:  Children (Basel)       Date:  2019-10-24

10.  Elevated FiO2 increases SARS-CoV-2 co-receptor expression in respiratory tract epithelium.

Authors:  Despoina Myti; Miša Gunjak; Francisco Casado; Solmaz Khaghani Raziabad; Claudio Nardiello; István Vadász; Susanne Herold; Gloria Pryhuber; Werner Seeger; Rory E Morty
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-09-02       Impact factor: 6.011

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.